Home › Glaucoma › Maryland › Baltimore
Glaucoma clinical trials in Baltimore, MD
6 studies for Glaucoma are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Clarifying the Optimal Application of SLT Therapy Trial
RecruitingPhase 3
- Wilmer Eye Institute Johns Hopkins, Baltimore
Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy
RecruitingObservational studyHealthy volunteers welcome
- University of Maryland School of Medicine, Baltimore
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Recruiting
- Wilmer Eye Institute, Johns Hopkins University, Baltimore
Optic Nerve Head Strain in Non-glaucoma Subjects
RecruitingEarly phase 1Healthy volunteers welcome
- Johns Hopkins Hospital, Baltimore
Ocular Blood Flow Imaging for Glaucoma Assessment
RecruitingHealthy volunteers welcome
- University of Maryland Eye Associates at Redwood, Baltimore
Retinal Blood Flow and Autoregulation
RecruitingPhase 4Healthy volunteers welcome
- University of Maryland Faculty Physicians, Inc, Baltimore
- University of Maryland Medical Center, Baltimore
- University of Maryland, Baltimore, Baltimore
About Glaucoma
Glaucoma is a group of eye diseases that can damage the optic nerve and cause vision loss and blindness. A comprehensive eye exam can tell if you have glaucoma.
More about Glaucoma on MedlinePlus
Glaucoma trials in other cities
- San Francisco, CA5 studies
- Durham, NC5 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Mountain View, CA4 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Cancer (all types)38 studies
- Pancreatic Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Bladder Cancer24 studies
- Heart Failure24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.